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Introduction 
Sarcomas are a diverse group of tumours, malignant in 
nature, with different clinical features and outcome. 
These rare tumours arise from skeletal and extra-skeletal 
connective tissues including the peripheral nervous 
system. They primarily affect the limbs, pelvic girdles and 
the retro-peritoneum but can occur in any part of the 
body.1,2 During recent years, a few case series have been 
published enhancing our understanding of the natural 
history following resection of these tumours.3 Although, 
our research has evolved greatly, these tumours are still 
resistant to chemotherapy and radiation in most cases 
hence surgical resection remains the mainstay of 
treatment.4 
Due to the relative rarity of these tumours, there is only a 
handful of literature available even during this day and 
age. The treatment strategies have changed over the 
years but one approach has been universally accepted by 
all tumour facilities around the globe which is the 
application of multimodal approach towards these 
tumours.5 This has drastically changed the outcomes of 
these sarcomas with more and more cases now being 
treated with curative and/or limb sparing intent. This was 
earlier considered as untreatable and hence dealt with a 
palliative goal.6-9 This was majorly true for sarcomas 
occurring in retroperitoneum and pelvis where they often 
tend to involve major blood vessels, putting the oncology 
clinicians and orthopaedic surgeons in a difficult 
situation.10 
In a developing country like Pakistan, where good health 
care facilities are still a dream yet to be achieved, having a 
tertiary care set up like The Aga Khan University Hospital, 
with a dedicated musculoskeletal oncology team 
comprising of highly trained oncologists, an orthopaedic 
tumour surgeon and vascular surgeons, is a blessing. 
However, the management and outcomes of soft tissue 
sarcomas in our part of the world have never been 
evaluated. Hence this study reviews the management and 
outcomes of soft tissue sarcomas, showing the frequency 
of the thigh, hip and groin sarcomas at our institute.  
Methods 
Data of soft tissue tumour patients registered from 2017-
2018 was retrieved during January 2019 to March 2019 
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Abstract 
Objective: To study the frequency of the thigh, hip and groin soft tissue sarcomas and retrospectively analyse the 
management, treatment results, and outcomes of these uncommon malignant tumours, in a tertiary care hospital 
of the city of Karachi.  
Methodology: Data of soft tissue tumours registered from 2017-2018 was retrieved during January 2019 to March 
2019 from Aga Khan University Hospital, Karachi bone and soft tissue tumour registry. A retrospective review was 
performed and all soft tissue tumour cases treated with surgical intervention (with adjuvant /neoadjuvant therapy) 
or palliative intention were included. 
Result: Total 119 cases of soft tissue tumours (STS) were identified out of which 85 were malignant cases (sarcomas) 
while 30 were benign. On presentation 84 (70.6%) were primary cases. On topographical distribution, there were 25 
patients who had hip, groin and thigh sarcoma. Of these, 15 were males and 10 were females.  As treatment, neo-
adjuvant radiation was done in 4 (16%) patients and adjuvant chemo/radio therapy was given to 13 (52%) patients. 
Wide margin excision was performed in 19 (76%) patients and 4 (16%) had amputation.  Reconstruction was offered 
to 3 (12%) patients. In post-surgical complications, 1 (4%) patient had wound infection. On final surgical 
histopathology, majority of the sarcomas were liposarcomas, myxofibrosarcoma, synovial sarcoma and 
Leiomyosarcoma.  Post-surgery recurrence occurred in 7 (28%) patients. Overall survival was 76%.  
Conclusion: In treatment of soft tissue sarcoma, limb salvage is an achievable option and survival results are also 
good.  
Keywords: Limb salvage, Synovial sarcoma, Radiotherapy, Recurrence, Leiomyosarcoma. 
(JPMA 71: S-75 [Suppl. 5]; 2021)
from Aga Khan University Hospital bone and soft tissue 
tumour registry. A retrospective review of cases was 
conducted at the Aga Khan University Hospital, Karachi, 
department of Orthopaedics after getting exemption 
from the institute ethical review committee.  The data was 
retrieved from the bone and soft tissue registry proforma 
which had been filled at the initial visit of the patient and 
completed at the final follow up. The detailed proforma 
comprised of patient demographics (age, gender, 
comorbidities, hospital medical record number etc.), 
tumour related details, investigation details, treatment 
details, surgical details and post treatment details 
(complications, recurrence, survival). All soft tissue 
tumour cases treated with surgical intervention (with 
adjuvant /neo-adjuvant therapy) or palliative intention 
were included irrespective of age and gender. For tumour 
staging, American joint commission center (AJCC) staging 
system was used.11 Data was stratified later as per 
objective requirements by topographic distribution as 
cases of hip, groin and thigh. Data was entered and 
analyzed on statistical software SPSS 21. Descriptive 
statistics was calculated for quantitative variables while 
frequencies were calculated for qualitative variables.   
Result 
There were 119 cases of soft tissue tumours (STS) out of 
which 85(71.4%) were malignant cases (sarcomas) while 
30(25.2%) were benign and 
4(3,36%) were borderline. On 
presentation there were 84 (70.6%) 
primary cases, 24 (20 %) recurrent 
cases and 6 (5%) metastatic cases 
while 5 (4.2%) were residual. Since 
our focus was on analysing 
management outcomes in groin, 
hip and thigh soft tissue sarcomas 
there were total 25 (21%) patients, 
out of which 19 (76%) cases of 
thigh, 5 (20%) of hip and 1 (4%) of 
groin sarcoma. On presentation, 
the mean age of patient at the time 
of diagnoses was 46±15 (17-70) 
years. The mean follow up of 
patients was 19±11.9 months. 
There were 15 (60%) males and 10 
(40%) females. For treatment, neo-
adjuvant radiation was done in 4 
(16%) patients whereas adjuvant 
therapy, chemo/radiation was 
given to 13 (52%) patients (Table). 
Curative intent was applied to 23 
(92%) patients while 2 (8%) were 
treated with palliative intent. Of all the patients, 19 (76%) 
underwent wide margin excision and 4(16%) had 
amputation, 2(8%) had only diagnostic biopsies. 
Reconstruction was offered to 3(12%) patients which 
included vascular repair of femoral artery with 
contralateral reversed greater saphenous vein 
interposition graft, soft tissue graft and intramedullary 
nailing with free vascular fibula graft. In post-surgical 
complications, 1 (4%) patient had wound infection which 
was treated with oral antibiotics while 1 (4%) had 
iatrogenic injury in another hospital and was presented to 
us for a redo procedure. On final surgical histopathology, 
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Table: Summary of Surgical and Non-Surgical Intervention. 
 
Variables                                                                                             n                                            % 
 
Curative surgery                                                                                 23                                           92 
Palliative surgery                                                                                2                                             8 
Neo Adjuvant radiotherapy                                                              4                                            16 
No Neo Adjuvant radiotherapy                                                      21                                           84 
Adjuvant chemo/radiation                                                              13                                           52 
No adjuvant chemo/radiation                                                        12                                           48 
Wide margin excision                                                                       19                                           76 
Amputation                                                                                          4                                            16 
Diagnostic biopsy                                                                                2                                             8 
Reconstruction                                                                                     3                                            12 
No reconstruction                                                                               22                                           88
Figure: Post surgery histopathological findings of patients (tumour).
majority of the sarcomas were liposarcomas as it was 
reported in 6(24%) patients, 3(12%) patients had 
Leiomyosarcoma (Figure). Nine (36%) patients were of 
stage III B followed by 6 (24%) cases of stage IV and 2 (8%) 
were stage II and rest were stage I cases. Post-surgery 
recurrence occurred in 7 (28%) patients, out of which 5 
(20%) had recurrence with Mets, 1(4%) had recurrence 
without Mets and 1(4%) had only distant metastasis to 
lungs. Two (8%) patients had positive margins on final 
histopathology report. Out of 25 patients, 19(76%) 
patients were alive in the two-year period, while only 6 
(24%) expired due to recurrence and metastasis.  
Discussion 
The present report highlights the advantages of having 
large focused prospective databases in tumour entities 
that are rare. Such datasets can be utilized not only for the 
prediction of prognostic factors but can identify varied 
and variable prognostic events at the time of presentation 
which influence the type of recurrence, i.e. disease 
specific survival, metastasis free survival, or overall 
survival.12-14 
Most importantly, they provide a stable description of 
patient specific outcomes in a series of rare diseases, 
giving a baseline for predicted outcome and risk.  
We conducted a retrospective analysis of prospectively 
collected data to assess the management strategies of 
these rare commodities employed at our institute and 
their outcomes with respect to histological type, post-
operative complications, local recurrence, metastasis and 
overall survival. Vascular reconstruction was not 
considered a contraindication in our setup and vessel 
reconstruction was done wherever desired. 
A multidisciplinary team was essential to our surgical 
approach. The preoperative team approach allowed for 
better surgical planning, removal of previously thought 
inoperable tumours based on outside hospital 
evaluations, more effective reconstruction, and improved 
outcomes.  
This series consisted of 25 patients (15 males, 10 females) 
which is comparable to other case series previously 
published.10,15-17 Twenty-three (92%) patients were 
treated with curative intent while only 2 (8%) were 
treated for palliation. Limb salvage was possible in 82% of 
patients treated with curative intent. Comparably, similar 
rates of limb salvage ranging from 80% to 100%.18-20 have 
been reported in the previously published case series 
with similar number of cases. 
We reported a wound complication rate of 4% which is 
significantly lower than other studies. Song et al. and 
Adelani et al. reported wound complication rate of 36% 
and 50% respectively.15,21 
It is possible to obtain reasonably good survival rates with 
careful pre-operative planning and appropriate and 
timely intervention. Recurrence of tumour remains an 
issue however. The use of adjuvant therapy in patients 
with limb sparing surgery for extremity STS has been 
widely accepted. Schwarzbach et al. report recurrence in 
15.8% (n=3) of 19 patients in their study.10 A slightly 
higher figure of 21% has been reported by Song et al.15 
Our study reports a recurrence rate of 28% (n=7) of 25 
patients, 5 of which had recurrence with metastatic 
disease, one developed recurrence without metastasis 
and one had only distant metastasis (lungs). This high 
recurrence rate despite the fact that 52% of our patients 
received adjuvant therapy but still the survival rate in our 
patients was 76%. 
Soft tissue sarcomas are classified histologically according 
to the soft tissue cell of origin, although the cell type is not 
part of the prognostic staging system. Additional studies, 
including electron microscopy, histochemistry, and flow 
cytometry, cytogenetic and tissue culture studies may 
allow identification of particular subtypes within the 
major histologic categories. Malignant fibrous 
histiocytoma is the most common histologic type (28%). 
Others are leiomyosarcoma (12%), liposarcoma (15%), 
synovial sarcoma (10%), and malignant peripheral nerve 
sheath tumour (6%).22 In our study however, liposarcoma 
was the most common histological type occurring in 24% 
of the patients. Other types included myxofibrosarcomas, 
synovial sarcoma and Leiomyosarcoma each reported in 
12% patients. Other less common types included 
pleomorphic sarcoma, malignant peripheral nerve sheath 
tumour and rahabdomyosarcoma that were found in 8% 
patients.  
Conclusion 
The treatment of patients with STS involves a 
multidisciplinary team approach and most patients are 
eligible for limb-salvage surgery, usually combined with 
radiation. Following treatment the majority of patients 
can expect a painless and functional extremity.  
Limitations 
This study, however, has some limitations. Firstly this 
study has a retrospective design which makes the inferior 
level of evidence compared to prospective studies and 
also this study is inherently prone to recall bias. Secondly, 
the sample size is very small and are thus not 
representative of the general population. 
Vol. 71, No. 8 (Suppl. 5), August 2021
S-77 34th International Pak OrthoCon Conference 2021
Disclaimer: None. 
Conflict of Interest: None. 
Funding Disclosure: None. 
References 
1. Group EESNW. Gastrointestinal stromal tumors: ESMO Clinical 
Practice Guidelines for diagnosis, treatment and follow-up. ANN 
ONCOL: official journal of the European Society for Medical 
Oncology. 2012; 23:vii49. 
2. Stiller C, Trama A, Serraino D, Rossi S, Navarro C, Chirlaque M, et al. 
Descriptive epidemiology of sarcomas in Europe: report from the 
RARECARE project. Eur. J. Cancer. 2013; 49:684-95. 
3. Brennan MF, Antonescu CR, Moraco N, Singer S. Lessons learned 
from the study of 10,000 patients with soft tissue sarcoma. ANN 
SURG. 2014; 260:416. 
4. Bonvalot S, Raut CP, Pollock RE, Rutkowski P, Strauss DC, Hayes AJ, 
et al. Technical considerations in surgery for retroperitoneal 
sarcomas: position paper from E-Surge, a master class in sarcoma 
surgery, and EORTC-STBSG.ANN SURG ONCOL. 2012; 19:2981-91. 
5. McGoldrick NP, Butler JS, Lavelle M, Sheehan S, Dudeney S, 
O'Toole GC. Resection and reconstruction of pelvic and extremity 
soft tissue sarcomas with major vascular involvement: current 
concepts.World J. Orthop.2016; 7:293. 
6. Enneking W. Giant cell tumor of bone: Musculoskeletal tumor 
surgery, New York. 1983; pp1435-68. 
7. Enneking WF, Spanier SS, Goodman MA. The classic: A system for 
the surgical staging of musculoskeletal sarcoma. Clin. Orthop. 
Relat. Res.2003; 415:4-18 
8. Willard W. Comparison of amputation with limb-sparing 
operations for adult soft tissue sarcoma of the extremity.Plast. 
Reconstr. Surg.1993; 91:571. 
9. Suit HD, Mankin HJ, Wood WC, Proppe KH. Preoperative, 
intraoperative, and postoperative radiation in the treatment of 
primary soft tissue sarcoma. Cancer. 1985; 55:2659-67. 
10. Schwarzbach MH, Hormann Y, Hinz U, Leowardi C, Böckler D, 
Mechtersheimer G, et al. Clinical results of surgery for 
retroperitoneal sarcoma with major blood vessel involvement. J 
Vasc. Surg.2006; 44:46-55. 
11. Tanaka K, Ozaki T. New TNM classification (AJCC eighth edition) of 
bone and soft tissue sarcomas: JCOG Bone and Soft Tissue Tumor 
Study Group.Jpn. J. Clin. Oncol. 2019; 49:103-7. 
12. Singer S, Antonescu CR, Riedel E, Brennan MF. Histologic subtype 
and margin of resection predict pattern of recurrence and survival 
for retroperitoneal liposarcoma. Ann. Surg. 2003; 238:358. 
13. Pisters PW, Harrison LB, Leung D, Woodruff JM, Casper ES, 
Brennan MF. Long-term results of a prospective randomized trial 
of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol. 
1996; 14:859-68. 
14. Pisters PW, Leung D, Woodruff J, Shi W, Brennan MF. Analysis of 
prognostic factors in 1,041 patients with localized soft tissue 
sarcomas of the extremities. J Clin Oncol. 1996; 14:1679-89. 
15. Song TK, Harris EJ, Raghavan S, Norton JA. Major blood vessel 
reconstruction during sarcoma surgery. Arch Surg. 2009; 144:817-22. 
16. Nishinari K, Wolosker N, Yazbek G, Zerati AE, Nishimoto IN. Venous 
reconstructions in lower limbs associated with resection of 
malignancies. J Vasc Surg. 2006; 44:1046-50. 
17. Tsukushi S, Nishida Y, Sugiura H, Nakashima H, Ishiguro N. Results 
of limb?salvage surgery with vascular reconstruction for soft 
tissue sarcoma in the lower extremity: comparison between only 
arterial and arterovenous reconstruction. J Surg. Oncol. 2008; 
97:216-20. 
18. Fortner JG, Kim DK, Shiu MH. Limb-preserving vascular surgery for 
malignant tumors of the lower extremity. Arch Surg. 1977; 
112:391-4. 
19. Karakousis CP, Karmpaliotis C, Driscoll DL. Major vessel resection 
during limb-preserving surgery for soft tissue sarcomas. World J 
Surg. 1996; 20:345-50. 
20. Hohenberger P, Allenberg JR, Schlag PM, Reichardt P. Results of 
surgery and multimodal therapy for patients with soft tissue 
sarcoma invading to vascular structures. Cancer: Interdisciplinary 
International Journal of the American Cancer Society. 1999; 
85:396-408. 
21. Adelani MA, Holt GE, Dittus RS, Passman MA, Schwartz HS. 
Revascularization after segmental resection of lower extremity 
soft tissue sarcomas. J Surg Oncol. 2007; 95:455-60. 
22. Puri A, Gulia A. Management of extremity soft tissue sarcomas. 
Indian J Orthopaed. 2011; 45:301.
J Pak Med Assoc (Suppl. 5)
34th International Pak OrthoCon Conference 2021 S-78
